Genetics and Public Health: Disease Control and Prevention Proposal

Exclusively available on Available only on IvyPanda® Written by Human No AI

Summary

The proposed research is focused on the problem of disease control and prevention as key target areas for the public with the use of genetics. The purpose of the study is to explore and identify the genetic factors involved in cancer genetics by focusing on genetic epidemiology and population genetics. The results will be significant in contributing to the growing body of knowledge as well as enabling more evidence-based public health legislation. Research questions:

  • How is a person’s genetic makeup significant in predicting the risk of cancer?
  • What genetic factors have a correlational relationship with cancer development?

Literature Review

The body of literature on the topic is constantly expanding, but they come in specialized chunks making it difficult to conduct generalized categorizations. Studies suggest that there are genetic susceptibility markers for prostate cancer identifiable within a family unit (Rebbeck, 2017; Cott, 2020). Gene mapping revealed that there is the “recurrence of 301 unique resistance alleles across 1934 drug-resistant tumors” (Forbes et al., 2017, p 777). The current system of public health underuses genetic epidemiology and population genetics (Hinchcliff et al., 2019; Solomon, 2022). For example, “heritable factors account for approximately 35% of colorectal cancer (CRC) risk, and almost 30% of the population … have a family history of CRC” (Monahan et al., 2020, p. 411). A more prominent case of cancer genetics being critical is breast cancer, which is becoming under-prioritized in public health due to COVID-19 (Yin et al., 2020; Li et al., 2018). Similarly, hereditary genetic factors can be more prevalent in certain groups than others, such as Latino women being more vulnerable to breast and ovarian cancers (Correa-Cruz et al., 2017; Roy & Datta, 2020). Thus, the presence and influence of genetic factors are evident.

There is a need to develop and identify relevant biomarkers in cancer genetics epidemiology for Canada. A global study found that “cancer among women could be substantially reduced in both HICs and LMICs through the broad and equitable implementation of effective interventions, including tobacco control, HPV and HBV vaccination, and screening” (Torre et al., 2017, p. 444). A more action-oriented research concluded that “practitioners and clinicians may better help breast cancer prognosis be improved through exercise, anticipating physiological effects on cancer” (Kang et al., 2017, p. 355). It is important to account for tobacco products, especially newly modified tobacco products, as biomarkers as well (Chang et al., 2017). It might be useful to analyze the cancer treatment survival rates to identify their role in cancer genetics epidemiology (Bryant et al., 2017). Therefore, there is a range of biomarkers and factors which can be assessed in regard to cancer.

Methodology

It should be noted that the methodology for the research is quantitative, where data will be derived from PubMed, EMBASE, CENTRAL, CINAHL, and other databases. The selection will be focused on the Canadian population and its relevance to the research questions. Due to the heterogeneity of cancer as a collection of diseases, accounting for diagnostic sites of the human body might be more practical for the given research methodology (Noone et al., 2017). The sample will be dependent on the collected information, but it is expected to be large enough to make epidemiological conclusions. Variables will include biomarkers, hereditary factors, and other critical influencing elements. The instrument is not completely determined, but R software can prove to be useful for statistical assessments.

References

Bryant, A. K., Banegas, M. P., Martinez, M. E., Mell, L. K., & Murphy, J. D. (2017). . Cancer Epidemiology, Biomarkers & Prevention, 26(6), 963-970. Web.

Chang, C. M., Edwards, S. H., Arab, A., Valle-Pinero, A. Y. D., Yang, L., & Hatsukami, D. K. (2017). . Cancer Epidemiology, Biomarkers & Prevention, 26(3), 291-302. Web.

Correa-Cruz, M., Perez-Mayoral, J., Dutil, J., Echenique, M., Mosquera, R., Rivera-Roman, K., Umpierre, S., Rodriguez-Quilichini, S., Gonzalez-Pons, M., Olivera, M. I., & Pardo, S. (2017). . Journal of Genetic Counseling, 26, 379-386. Web.

Cott, C. V. (2020). . Surgical Clinics, 100(3), 483-498. Web.

Forbes, S. A., Beare, D., Boutselakis, H., Bamford, S., Bindal, N., Tate, J., Cole, C. G., Ward, S., Dawson, E., Ponting, E., Stefancsik, R., Harsha, B., Kok, C. Y., Jia, M., Jubb, H., Sondka, Z., Thompson, S., De, T., & Campbell, P. J. (2017). . Nucleic Acids Research, 45(1), 777-783. Web.

Hinchcliff, E. M., Bednar, E. M., Lu, K. H., & Rauh-Hain, J. A. (2019). . Gynecologic Oncology, 153(1), 184-191. Web.

Kang, D. W., Lee, J., Suh, S. H., Ligibel, J., Courneya, K. S., & Jeon, J. Y. (2017). . Cancer Epidemiology, Biomarkers & Prevention, 26(3), 355-365. Web.

Li, C. C., Shen, Z., Bavarian, R., Yang, F., & Bhattacharya, A. (2018). . Oral Cancer, 62(1), 29-46. Web.

Monahan, K. J., Bradshaw, N., Dolwani, S., Desouza, B., Dunlop, M. G., East, J. E., Ilyas, M., Kaur, A., Lalloo, F., Latchford, A., Rutter, M. D., Tomlinson, I., Thomas, H. J. W., & Hill, J. (2020). . Gut, 69(3), 411-444. Web.

Noone, A. M., Cronin, K. A., Altekruse, S. F., Howlader, N., Lewis, D. R., Petkov, V. I., & Penberthy, L. (2017). . Cancer Epidemiology, Biomarkers & Prevention, 26(4), 632–641. Web.

Rebbeck, T. R. (2017). . Seminars in Radiation Oncology, 27(1), 3-10. Web.

Roy, M., & Datta, A. (2020). Cancer genetics and therapeutics: Focus on phytochemicals. Springer.

Solomon, B. D. (2022). Medical genetics and genomics. Wiley-Blackwell.

Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017). . Cancer Epidemiology, Biomarkers & Prevention, 26(4), 444-457. Web.

Yin, K., Singh, P., Drohan, B., & Hughes, K. S. (2020). . Cancer, 126(20), 4466-4472. Web.

More related papers Related Essay Examples
Cite This paper
You're welcome to use this sample in your assignment. Be sure to cite it correctly

Reference

IvyPanda. (2024, March 29). Genetics and Public Health: Disease Control and Prevention. https://ivypanda.com/essays/genetics-and-public-health-disease-control-and-prevention/

Work Cited

"Genetics and Public Health: Disease Control and Prevention." IvyPanda, 29 Mar. 2024, ivypanda.com/essays/genetics-and-public-health-disease-control-and-prevention/.

References

IvyPanda. (2024) 'Genetics and Public Health: Disease Control and Prevention'. 29 March.

References

IvyPanda. 2024. "Genetics and Public Health: Disease Control and Prevention." March 29, 2024. https://ivypanda.com/essays/genetics-and-public-health-disease-control-and-prevention/.

1. IvyPanda. "Genetics and Public Health: Disease Control and Prevention." March 29, 2024. https://ivypanda.com/essays/genetics-and-public-health-disease-control-and-prevention/.


Bibliography


IvyPanda. "Genetics and Public Health: Disease Control and Prevention." March 29, 2024. https://ivypanda.com/essays/genetics-and-public-health-disease-control-and-prevention/.

If, for any reason, you believe that this content should not be published on our website, you can request its removal.
Updated:
This academic paper example has been carefully picked, checked and refined by our editorial team.
No AI was involved: only quilified experts contributed.
You are free to use it for the following purposes:
  • To find inspiration for your paper and overcome writer’s block
  • As a source of information (ensure proper referencing)
  • As a template for you assignment
1 / 1